Daniel Wendling is at the Department of Rheumatology, University Teaching Hospital, CHRU de Besançon, Boulevard Alexandre Fleming, 25030 Besançon, France; and at EA4266, Université Bourgogne-Franche-Comté, 32 Avenue de l'Observatoire, 25030 Besançon, France.Clément Prati is at the Department of Rheumatology, University Teaching Hospital, CHRU de Besançon, Boulevard Alexandre Fleming, 25030 Besançon, France; and at EA4267, Fédération Hospitalo-Universitaire Integrates Centre for Research in Inflammatory Diseases (FHU INCREASE), Université Bourgogne-Franche-Comté, 25030 Besançon, France.
Checking for direct PDF access through Ovid
Updated recommendations for the management of axial spondyloarthritis provide a useful framework for physicians treating this disease. However, the guidance on use of biologic therapies and treat-to-target strategies seems to raise more questions than it answers.Refers to Van der Heijde, D. et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann. Rheum. Dis.http://dx.doi.org/10.1136/annrheumdis-2016-210770 (2017)